Published in Endocrinology on February 01, 1975
Binding of insulin to isolated nuclei. Proc Natl Acad Sci U S A (1976) 1.34
Thyroid hormone binding by a component of mitochondrial membrane. Proc Natl Acad Sci U S A (1975) 1.08
Polychlorinated biphenyls (PCBs) exert thyroid hormone-like effects in the fetal rat brain but do not bind to thyroid hormone receptors. Environ Health Perspect (2004) 1.07
Stereospecific transport of triiodothyronine from plasma to cytosol and from cytosol to nucleus in rat liver, kidney, brain, and heart. J Clin Invest (1985) 1.01
Biochemical and stereological analysis of rat liver mitochondria in different thyroid states. J Cell Biol (1978) 0.98
Relationship of receptor affinity to the modulation of thyroid hormone nuclear receptor levels and growth hormone synthesis by L-triiodothyronine and iodothyronine analogues in cultured GH1 cells. J Clin Invest (1979) 0.96
Development of the lung liquid reabsorptive mechanism in fetal sheep: synergism of triiodothyronine and hydrocortisone. J Physiol (1991) 0.91
Characterization of a thyroid-hormone-binding site on nuclear envelopes and nuclear matrices of the male-rat liver. Biochem J (1984) 0.83
Binding of triiodothyronine by fully differentiated rat enterocytes. J Physiol (1986) 0.78
Altered function of peripheral organ systems in rats exposed to chronic mild stress model of depression. Cell Mol Neurobiol (2001) 0.76
The mitochondrial route of thyroid hormone action. Bull N Y Acad Med (1977) 0.75
Peripheral metabolism of hormones: clinical implications. J R Soc Med (1979) 0.75
A new unextracted-sample radioimmunoassay method for hepatic endogenous nuclear L-tri-iodothyronine content. Validity of its use in determining nuclear receptor binding characteristics. Biochem J (1982) 0.75
Familial syndrome combining deaf-mutism, stuppled epiphyses, goiter and abnormally high PBI: possible target organ refractoriness to thyroid hormone. J Clin Endocrinol Metab (1967) 2.47
Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma. N Engl J Med (1997) 2.20
Moderate hypothyroidism in preparation for whole body 131I scintiscans and thyroglobulin testing. Thyroid (1996) 2.05
CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol (2000) 1.99
A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab (1999) 1.92
Generalized resistance to thyroid hormone associated with a mutation in the ligand-binding domain of the human thyroid hormone receptor beta. Proc Natl Acad Sci U S A (1989) 1.85
Anti-thyroid peroxidase antibody in patients with autoimmune thyroid disease: possible identity with anti-microsomal antibody. J Clin Endocrinol Metab (1985) 1.69
The morning-report syndrome and medical search. N Engl J Med (1979) 1.53
CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J Clin Endocrinol Metab (1995) 1.49
Graves' disease in severe combined immunodeficient mice. J Clin Endocrinol Metab (1995) 1.46
Decreased levels of helper T cells: a possible cause of immunodeficiency in pregnancy. N Engl J Med (1982) 1.46
Recessive inheritance of thyroid hormone resistance caused by complete deletion of the protein-coding region of the thyroid hormone receptor-beta gene. J Clin Endocrinol Metab (1992) 1.40
Immunosuppression of thyroiditis. Endocrinology (1996) 1.39
Congenital goiter and the development of metastatic follicular carcinoma with evidence for a leak of nonhormonal iodide: clinical, pathological, kinetic, and biochemical studies and a review of the literature. J Clin Endocrinol Metab (1981) 1.36
Characterization of a thyroid hormone receptor expressed in human kidney and other tissues. Proc Natl Acad Sci U S A (1988) 1.33
Thyrotrophin-induced aggregation and reorganization into follicles of isolated porcine-thyroid cells. 1. Mechanism of action of thyrotrophin and metabolic properties. Eur J Biochem (1971) 1.29
Dominant negative transcriptional regulation by a mutant thyroid hormone receptor-beta in a family with generalized resistance to thyroid hormone. Mol Endocrinol (1990) 1.26
Long-term follow-up study of compensated low-dose 131I therapy for Graves' disease. N Engl J Med (1984) 1.18
Characterization of a third human thyroid hormone receptor coexpressed with other thyroid hormone receptors in several tissues. Mol Endocrinol (1988) 1.16
Studies on suppressor cell function in thyroid diseases. J Clin Endocrinol Metab (1979) 1.16
Nomenclature of thyroid hormone receptor beta-gene mutations in resistance to thyroid hormone: consensus statement from the first workshop on thyroid hormone resistance, July 10-11, 1993, Cambridge, United Kingdom. J Clin Endocrinol Metab (1994) 1.15
Decreased suppressor T-lymphocytes in autoimmune thyroid diseases detected by monoclonal antibodies. J Clin Endocrinol Metab (1982) 1.15
Studies of a sibship with apparent hereditary resistance to the intracellular action of thyroid hormone. Metabolism (1972) 1.10
A human early response gene homologous to murine nur77 and rat NGFI-B, and related to the nuclear receptor superfamily. Mol Endocrinol (1990) 1.10
Changes in thyroid-stimulating immunoglobulins during antithyroid therapy. J Clin Endocrinol Metab (1979) 1.09
Retrospective and prospective study of radiation-induced thyroid disease. Am J Med (1983) 1.08
Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer. J Clin Endocrinol Metab (1994) 1.08
Binding of T3 in rat liver nuclei. Endocrinology (1974) 1.06
Identification of a thyroid microsomal antigen by Western blot and immunoprecipitation. J Clin Endocrinol Metab (1985) 1.06
Triiodothyronine binding to liver nuclear solubilized proteins in vitro. Endocrinology (1975) 1.06
Kinetic analysis of iodine metabolism. J Clin Endocrinol Metab (1966) 1.04
Isolation of a complementary DNA clone for thyroid microsomal antigen. Homology with the gene for thyroid peroxidase. J Clin Invest (1987) 1.02
[Symptomatology of hydatid cyst of the heart. Study of a continuous series of 13 cases and value of x-ray computed tomography]. Arch Mal Coeur Vaiss (1985) 1.02
Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study). J Clin Endocrinol Metab (1994) 1.02
Coupled oxidative phosphorylation in muscle of thyrotoxic patients. Am J Med (1968) 1.01
Human histocompatibility leukocyte antigen-DQA1*0501 allele associated with genetic susceptibility to Graves' disease in a Caucasian population. J Clin Endocrinol Metab (1993) 1.01
High affinity and specificity of dimeric binding of thyroid hormone receptors to DNA and their ligand-dependent dissociation. Mol Endocrinol (1993) 1.01
Pacemaker syndrome with DDD pacing. Pacing Clin Electrophysiol (1984) 1.00
Structural analysis of human thyroid hormone receptor beta gene. Mol Cell Endocrinol (1990) 0.99
Molecular cloning of the complementary deoxyribonucleic acid for human thyroid peroxidase. Mol Endocrinol (1987) 0.99
Abnormalities of triiodothyronine binding to lymphocyte and fibroblast nuclei from a patient with peripheral tissue resistance to thyroid hormone action. J Clin Endocrinol Metab (1978) 0.99
A nomenclature for tests of thyroid hormones in serum: report of a committee of the American Thyroid Association. J Clin Endocrinol Metab (1972) 0.98
Screening of nineteen unrelated families with generalized resistance to thyroid hormone for known point mutations in the thyroid hormone receptor beta gene and the detection of a new mutation. J Clin Invest (1991) 0.98
Study of circulating immune complexes in thyroid diseases: comparison of Raji cell radioimmunoassay and specific thyroglobulin-antithyroglobulin radioassay. J Clin Endocrinol Metab (1979) 0.97
Treatment of Graves' disease and the course of ophthalmopathy. Am J Med (1989) 0.97
Binding of human thyrotropin receptor peptides to a Graves' disease-predisposing human leukocyte antigen class II molecule. J Clin Endocrinol Metab (2000) 0.96
Hürthle cell tumors: a twenty-five-year experience. Surgery (1986) 0.96
The effect of hepatic enzyme-inducing drugs on thyroid hormones and the thyroid gland. Endocr Rev (1991) 0.95
[Biosynthesis, iodination and heterogeneity of thyroglobulin]. Bull Soc Chim Biol (Paris) (1965) 0.95
[Identification of eight new mutations in the c-erbAB gene of patients with resistance to thyroid hormone]. Ann Endocrinol (Paris) (2001) 0.94
Iodination and biosynthesis of rat thyroglobulin. Biochem Biophys Res Commun (1964) 0.93
Long-term follow-up of patients treated with VVI pacing and sequential pacing with special reference to VA retrograde conduction. Pacing Clin Electrophysiol (1988) 0.92
Antibodies against denatured and reduced thyroid microsomal antigen in autoimmune thyroid disease. J Clin Endocrinol Metab (1987) 0.92
Inherited disorders of thyroid metabolism. Endocr Rev (1983) 0.91
Serum thyroglobulin in the management of patients with thyroid cancer. Arch Intern Med (1982) 0.91
Microsomal antigen-reactive lymphocyte lines and clones derived from thyroid tissue of patients with Graves' disease. J Clin Endocrinol Metab (1988) 0.91
Remission of myasthenia and thyrotoxicosis after thymectomy. Ann Intern Med (1967) 0.91
In vitro binding of triiodothyronine to rat liver mitochondria. Pflugers Arch (1981) 0.91
Characterization of nuclear thyroid hormone receptors of cultured skin fibroblasts from patients with resistance to thyroid hormone. Metabolism (1987) 0.91
Calcitriol is a positive effector of adipose differentiation in the OB 17 cell line: relationship with the adipogenic action of triiodothyronine. Biochem Biophys Res Commun (1997) 0.89
Expression of three forms of thyroid hormone receptor in human tissues. Mol Endocrinol (1989) 0.89
Human lymphotoxin obtained from established lymphoid lines: purification characteristics and inhibition by anti-immunoglobulin. J Immunol (1974) 0.89
Effect of stable iodine on thyroid iodine release. J Clin Endocrinol Metab (1969) 0.89
Triiodothyronine and adipose conversion of OB17 preadipocytes : binding to high affinity sites and effects on fatty acid synthetizing and esterifying enzymes. J Recept Res (1981) 0.89
Defective thyroglobulin export as a cause of congenital goitre. Clin Endocrinol (Oxf) (1975) 0.89
Studies of immunoglobulin synthesis in cultures of peripheral T and B lymphocytes: reduced T-suppressor cell activity in Graves' disease. Clin Endocrinol (Oxf) (1983) 0.89
Diurnal rhythm in total serum thyroxine levels. Metabolism (1971) 0.89
Observations on the role of circulating lymphocytes in thyroid auto-immunity. J Clin Endocrinol Metab (1969) 0.88
Detection of a new de novo mutation at codon 251 of exon 8 of thyroid hormone receptor beta gene in an Italian kindred with resistance to thyroid hormone. J Endocrinol Invest (1998) 0.88
Production of thyroid-stimulating antibodies in mice by immunization with T-cell epitopes of human thyrotropin receptor. Endocrinology (1995) 0.88
Thyrotropin-receptor and thyroid peroxidase-specific T cell clones and their cytokine profile in autoimmune thyroid disease. J Clin Endocrinol Metab (1997) 0.87
Clinical experience in transvenous and myocardial pacing. Ann N Y Acad Sci (1969) 0.87
Cloning and initial characterization of human and mouse Spot 14 genes. FEBS Lett (1997) 0.87
Dinucleotide repeat polymorphism in the human thyroid hormone receptor beta gene (THRB) on chromosome 3. Nucleic Acids Res (1991) 0.87
N-ras mutation: an independent prognostic factor for aggressiveness of papillary thyroid carcinoma. Surgery (1994) 0.87
Genetic linkage studies of thyroid peroxidase (TPO) gene in families with TPO deficiency. J Clin Endocrinol Metab (1991) 0.86
Cloning and characterization of the human thyroid hormone receptor beta 1 gene promoter. Biochem Biophys Res Commun (1992) 0.86
[Cardiac assistance with a pulsed arteriovenous shunt. Experimental study]. Arch Mal Coeur Vaiss (1969) 0.86
Vitiligo in Graves' disease. Ann Intern Med (1969) 0.86
Thyroid carcinoma. Med Clin North Am (1975) 0.86
Antipeptide polyclonal antibodies specifically recognize each human thyroid hormone receptor isoform. Endocrinology (1992) 0.86
Low-dose sodium iodide I 131 therapy in Graves disease. JAMA (1973) 0.85
Nuclear thyroid hormone receptors in cultured human fibroblasts: improved method of isolation, partial characterization, and interaction with chromatin. Metabolism (1986) 0.85
Reduced nuclear triiodothyronine receptors in starvation-induced hypothyroidism. Biochem Biophys Res Commun (1977) 0.85
Factors influencing triiodothyronine binding properties of liver nuclear receptors. Acta Endocrinol (Copenh) (1976) 0.85
Peroxidase deficiency in familial goiter with iodide organification defect. N Engl J Med (1971) 0.85
Peroxidase defect in congenital goiter with complete organification block. J Clin Endocrinol Metab (1973) 0.85
Long-term impact of initial and surgical therapy on papillary and follicular thyroid cancer. Am J Med (1994) 0.84
Thyroid and the heart. Mayo Clin Proc (1972) 0.84
A new solid-phase radioimmunoassay to measure IgG secreted by cultured human lymphocytes. J Immunol Methods (1980) 0.84
Peroxidase and NADPH-cytochrome C reductase activity during thyroid hyperplasia and involution. Endocrinology (1974) 0.84
Purification and characterization of rat liver nuclear thyroid hormone receptors. Proc Natl Acad Sci U S A (1987) 0.83
Action of potassium iodide on thyroxine metabolism. J Clin Endocrinol Metab (1966) 0.83
HLA class II associations in African-American female patients with Graves' disease. Thyroid (1996) 0.83
Studies on thyroglobulin-specific suppressor T cell function in autoimmune thyroid disease. J Clin Endocrinol Metab (1985) 0.83
The dominant negative effect of thyroid hormone receptor splicing variant alpha 2 does not require binding to a thyroid response element. Mol Endocrinol (1995) 0.83
Characterization of the thyroid microsomal antigen, and its relationship to thyroid peroxidase, using monoclonal antibodies. J Clin Invest (1988) 0.83
[Severe arterial hypertension. Treatment by stimulation of the carotid sinus nerve]. Arch Mal Coeur Vaiss (1967) 0.83